Eden Openly

Appraising the Cass Review

A note from Eden

I didn’t set out to appraise the Cass Review. But over the past few months it has been the piece of work I’ve been asked for most often.

A full re-review of all the evidence behind the Review is more than one researcher can do well, so I chose something narrower: to appraise the appraisal. That means asking whether the reviews the Review commissioned were soundly done, and whether the conclusions drawn from them follow.

I’m not neutral. I support responsible access to puberty blockers and hormone treatment for adolescents, and I’m saying so first because it matters for how you read what follows. I can’t promise that holding that view won’t affect my judgement; no one in my position honestly could. What I can do is fix the rules before I read, publish every judgement with its reasoning, and make it possible for you to check my work and see where you’d have called it differently.

The results will be what the method finds. Some may support my view and some may cut against it; both will be reported at full weight. My position and interests are set out in full below.

Eden

GUIDANCE APPRAISAL · GA-002 · IN PREPARATION

Eden Openly is carrying out a structured meta-appraisal of the Cass Review’s final report, published on 10 April 2024, and of the research it commissioned from the University of York. No findings have been published. None will be until the whole appraisal is complete, and then they will be released together.

What we are doing

The Review commissioned seven systematic reviews and an international survey of gender services. A meta-appraisal appraises an appraisal. The question is not what the right treatment is for gender-questioning young people. It is narrower. Were the commissioned reviews soundly conducted? Did the Review’s conclusions follow from what they found? How did the state act on them?

We keep three layers apart:

What it does not do

Where things stand

The appraisal runs in four stages, in this order:

  1. Methods registrationThe full protocol, frozen publicly before any scoring.We are here
  2. Claim registrationThe list of the Review’s claims to be appraised, frozen before any is scored.
  3. AppraisalScoring and judgement, in a random order, under the registered rules.
  4. Single releaseEvery result, record and correction, published together.

The methods are being finalised. Before any scoring begins, the full protocol will be frozen as a public registration on the Open Science Framework, with a published checksum, and mirrored on Zenodo with a DOI. A second registration then fixes the list of claims to be appraised before any of them is scored.

Until the methods are frozen, reading of the report and the York reviews is restricted by a written rule to what the method design needs. Every read, including a small feasibility pilot, is logged for publication. Registration does not mean we come to the Review unseen. It has been public and widely debated since 2024, and prior knowledge is recorded in an appendix of the registration.

The protocol

The protocol is not yet public. It is a working draft, and drafts are never posted, so that the only public version is the one frozen before scoring. When it is registered, its link, DOI and checksum will appear here.

If this page and the registered protocol ever differ, the protocol governs.

Our position, and why we don’t claim neutrality

We don’t claim to be neutral. Eden is a transgender woman, with a personal stake in this subject.

Eden is a dermatologist. She holds a declared prior in favour of adolescent access to puberty blockers and gender-affirming hormones; the method is designed to make any resulting bias more visible and auditable, and findings that cut against that position are reported at full weight.

Nothing in this appraisal rests on Eden’s clinical standing. Every judgement is published with its reasoning, for anyone to check.

She has further interests. All of them are listed, with the date each began, in our register of declared interests, and the protocol declares them in full. Those that bear on this appraisal are:

She also co-owns a commercial skincare business and is planning a general aesthetic hospital. That interest is in the register, and does not bear on this appraisal.

The appraisal is unfunded. Eden accepts no third-party funding for research, publication or appraisal, and pays every cost, including external review, herself.

Most of these interests create a plausible pull toward findings critical of the Review or of the policy that followed it. Declaring them doesn’t neutralise them. The method has to do that.

How the method guards against it

Fixing things in advance: commitments and public randomness

Several of the safeguards above depend on one thing: being able to show that something was fixed before an outcome could have influenced it. These include the claim list, the scoring order, the re-scoring samples, and each judgement before it is compared. We do this in two ways, and both can be checked by anyone without trusting us.

Commit now, reveal later

When a record has to be fixed before an outcome it constrains, for example a list of judgements before they are compared, we publish its fingerprint first: a SHA-256 hash, a short string that changes completely if a single character of the record changes. The record itself is published later, with everything else. Anyone can then hash it and confirm that it is the record we committed to. A commitment is not a publication. It shows what we had fixed and when, without revealing it early.

Public randomness

Where the method needs a random choice (the order in which claims are scored, or which judgements are re-scored), the random number must not be ours to pick. It is taken from a public randomness beacon: a service that publishes a new, unpredictable, cryptographically verifiable value at fixed intervals.

These steps prove timing and chance. They do not prove that a judgement is right. That is what the published reasoning, the blind re-scoring and the open error log are for.

The wider debate

Published criticism and defence of the Review are gathered by a registered search that runs identically for both sides. Each source’s declared interests are published as that source declared them, as context for readers, never as a substitute for engaging its argument.

Corrections and questions

If you’ve seen a claim about this project that doesn’t match this page, or you think we’ve got something wrong, please get in touch through our editorial contact page. Corrections are logged on our corrections page.

Eden Openly is an independent clinical health-education publication. It receives no funding from, and has no commercial relationship with, any provider of gender-related healthcare, any pharmaceutical company, or any supplier of NHS digital systems. This page describes a protocol in preparation; once the protocol is registered, it governs. Our full position on funding and interests is set out in our statement of independence, and every interest is listed, with its date, in our register of declared interests.

Revision history

Updated — 9 October 2026. Adds a section, “Fixing things in advance”, explaining how we commit to records before outcomes exist and how random choices are drawn from public randomness. It links to the new commitments page. The rest of the page is unchanged.

Updated — 7 October 2026. The appraisal’s identifier, GA-002, is now shown. It is the second in the Guidance Appraisal series, and it is carried out under its own registered method, not the method of the Verdict Series. The rest of the page is unchanged.

Updated — 30 September 2026. “Our position” now links to the new register of declared interests, which is the definitive, dated list, and names the non-profit as a transgender healthcare and education organisation, as the register does. It adds the author’s commercial interest in a skincare business and a planned aesthetic hospital, which does not bear on this appraisal but had not been stated here. The rest of the page is unchanged.

First published — 28 September 2026.